Market Research

Wound Closure Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 140 Pages Fortune Business Insights Pvt. Ltd. January, 2025 FOB19846991
Best Price Guarantee
Price from $4,850
Length 140 Pages
Publisher Fortune Business Insights Pvt. Ltd.
Published Date January, 2025
SKU FOB19846991

Growth Factors of Wound Closure Market

The Wound Closure Market size was valued at USD 13.80 billion in 2023. The market is projected tgrow from USD 23.51 billion in 2032, exhibiting a CAGR of 6.1% during the forecast period of 2024-2032.

The COVID-19 pandemic negatively impacted the wound closure marketplace due tdisruptions in healthcare services and supply chains. Elective surgical procedures, a huge motive force of wound closure products, were postponed or cancelled tprioritize COVID-19 cases, decreasing product demand. Lockdowns and manufacturing slowdowns led tdelays in production and distribution. Additionally, reduced clinic visits and patient reluctance tare looking for non-emergency care similarly constrained marketplace boom. However, call for wound care in trauma and critical care settings endured. As healthcare structures get better and elective procedures resume, the market is expected trebound, driven via innovation and increasing surgical methods globally.

A trend in the wound closure market is the development of superior adhesive technology that decorate restoration and minimize scarring. Innovations which include the Sylke Adhesive Wound Closure, identified in Allure's Best of Beauty 2024 Breakthrough Awards, exemplify this development. Sylke utilizes clinical-grade silk fibroin tcreate a bendy, non-worrying dressing that actions with the skin, providing better person comfort and progressed surgical results. Such improvements address barriers of conventional wound dressings, supplying advanced patient reviews and outcomes.

A driving factor for the wound closure marketplace is the rising incidence of persistent wounds and surgical tactics globally. Conditions inclusive of diabetes and weight problems make a contribution tthe growing incidence of ulcers and non-recovery wounds, necessitating advanced wound closure solutions. Additionally, the aging populace, more susceptible taccidents and surgical procedures, similarly boosts call for. Innovations in wound closure technologies, including absorbable sutures, adhesives, and minimally invasive gadgets, enhance healing effects and patient consolation. Increasing healthcare spending, specifically in rising economies, and the growing emphasis on enhancing postoperative care alsmake a contribution tthe expansion of the wound closure market.

Comprehensive Analysis of Wound Closure Market

The Wound Closure Market growth is rising at an exponential rate due tits marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by product type include sutures [absorbable and non-absorbable], hemostatic agents [active hemostats, passive hemostats, combination hemostats, and others], staplers [powered and manual], and others, by application include orthopedics, gynecology and obstetrics, general surgery, ophthalmology, cardiology, and others, by end-user include hospitals & ASCs, specialty clinics, and others.

The North America location lead the Wound Closure Market share percentage via benefitting a marketplace size of USD 5.20 billion due tincreasing number of surgical procedures, substantial healthcare expenditure & infrastructure, growing adoption rate, among others.

The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Boston Scientific Corporation, Frankenman International Ltd., CooperSurgical Inc., Intuitive Surgical, MANI,INC., Artivion, Inc.

March 2024: Intuitive Surgical secured 510(okay) clearance from the U.S. FDA for its da Vinci five, a next-technology multiport robotic machine. This advanced technology complements precision and flexibility in minimally invasive surgeries, reflecting Intuitive Surgical’s commitment tinnovation and enhancing surgical consequences in healthcare through current robot solutions.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.1% from 2024-2032

Unit Value (USD billion)

Segmentation By Product Type

  • Sutures
  • Absorbable
  • Non-Absorbable
  • Hemostatic Agents
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
  • Others
  • Staplers
  • Powered
  • Manual
  • Others
By Application
  • Orthopedics
  • Gynecology and Obstetrics
  • General Surgery
  • Ophthalmology
  • Cardiology
  • Others
By End-User
  • Hospitals & ASCs
  • Specialty Clinics
  • Others
By Region
  • North America (By Product Type, By Application, By End-User, and By Country)
  • U.S.
  • Canada
  • Europe (By Product Type, By Application, By End-User, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By End-User, and By Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By End-User, and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By End-User, and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Number of Key Procedures, by Key Countries/Region, 2023
4.2. New Product Launches - by Key Players
4.3. Technological Advancements in Wound Closure Market
4.4. Key Industry Developments - (Mergers, Acquisitions, Partnerships, etc.)
4.5. Impact of COVID-19 on the Wound Closure Market
5. Global Wound Closure Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Sutures
5.1.1.1. Absorbable
5.1.1.2. Non-absorbable
5.1.2. Hemostatic Agents
5.1.2.1. Active Hemostats
5.1.2.2. Passive Hemostats
5.1.2.3. Combination Hemostats
5.1.2.4. Others
5.1.3. Staplers
5.1.3.1. Powered
5.1.3.2. Manual
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Orthopedics
5.2.2. Gynecology and Obstetrics
5.2.3. General Surgery
5.2.4. Ophthalmology
5.2.5. Cardiology
5.2.6. Others
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & ASCs
5.3.2. Specialty Clinics
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Wound Closure Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Sutures
6.1.1.1. Absorbable
6.1.1.2. Non-absorbable
6.1.2. Hemostatic Agents
6.1.2.1. Active Hemostats
6.1.2.2. Passive Hemostats
6.1.2.3. Combination Hemostats
6.1.2.4. Others
6.1.3. Staplers
6.1.3.1. Powered
6.1.3.2. Manual
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Orthopedics
6.2.2. Gynecology and Obstetrics
6.2.3. General Surgery
6.2.4. Ophthalmology
6.2.5. Cardiology
6.2.6. Others
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals & ASCs
6.3.2. Specialty Clinics
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Wound Closure Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Sutures
7.1.1.1. Absorbable
7.1.1.2. Non-absorbable
7.1.2. Hemostatic Agents
7.1.2.1. Active Hemostats
7.1.2.2. Passive Hemostats
7.1.2.3. Combination Hemostats
7.1.2.4. Others
7.1.3. Staplers
7.1.3.1. Powered
7.1.3.2. Manual
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Orthopedics
7.2.2. Gynecology and Obstetrics
7.2.3. General Surgery
7.2.4. Ophthalmology
7.2.5. Cardiology
7.2.6. Others
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals & ASCs
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Wound Closure Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Sutures
8.1.1.1. Absorbable
8.1.1.2. Non-absorbable
8.1.2. Hemostatic Agents
8.1.2.1. Active Hemostats
8.1.2.2. Passive Hemostats
8.1.2.3. Combination Hemostats
8.1.2.4. Others
8.1.3. Staplers
8.1.3.1. Powered
8.1.3.2. Manual
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Orthopedics
8.2.2. Gynecology and Obstetrics
8.2.3. General Surgery
8.2.4. Ophthalmology
8.2.5. Cardiology
8.2.6. Others
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals & ASCs
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Wound Closure Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Sutures
9.1.1.1. Absorbable
9.1.1.2. Non-absorbable
9.1.2. Hemostatic Agents
9.1.2.1. Active Hemostats
9.1.2.2. Passive Hemostats
9.1.2.3. Combination Hemostats
9.1.2.4. Others
9.1.3. Staplers
9.1.3.1. Powered
9.1.3.2. Manual
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Orthopedics
9.2.2. Gynecology and Obstetrics
9.2.3. General Surgery
9.2.4. Ophthalmology
9.2.5. Cardiology
9.2.6. Others
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals & ASCs
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Wound Closure Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product Type
10.1.1. Sutures
10.1.1.1. Absorbable
10.1.1.2. Non-absorbable
10.1.2. Hemostatic Agents
10.1.2.1. Active Hemostats
10.1.2.2. Passive Hemostats
10.1.2.3. Combination Hemostats
10.1.2.4. Others
10.1.3. Staplers
10.1.3.1. Powered
10.1.3.2. Manual
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Application
10.2.1. Orthopedics
10.2.2. Gynecology and Obstetrics
10.2.3. General Surgery
10.2.4. Ophthalmology
10.2.5. Cardiology
10.2.6. Others
10.3. Market Analysis, Insights and Forecast – By End User
10.3.1. Hospitals & ASCs
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
10.4.1. GCC
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
11.2.1. Johnson & Johnson Services, Inc.
11.2.1.1. Overview
11.2.1.2. Products
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Baxter
11.2.2.1. Overview
11.2.2.2. Products
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Medtronic
11.2.3.1. Overview
11.2.3.2. Products
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Artivion, Inc.
11.2.4.1. Overview
11.2.4.2. Products
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Stryker
11.2.5.1. Overview
11.2.5.2. Products
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. 3M
11.2.6.1. Overview
11.2.6.2. Products
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. CP Medical (Riverpoint Medical)
11.2.7.1. Overview
11.2.7.2. Products
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Boston Scientific Corporation
11.2.8.1. Overview
11.2.8.2. Products
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Smith+Nephew
11.2.9.1. Overview
11.2.9.2. Products
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. B. Braun SE
11.2.10.1. Overview
11.2.10.2. Products
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. MANI, INC.
11.2.11.1. Overview
11.2.11.2. Products
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)
11.2.12. CONMED Corporation
11.2.12.1. Overview
11.2.12.2. Products
11.2.12.3. SWOT Analysis
11.2.12.4. Recent Developments
11.2.12.5. Strategies
11.2.12.6. Financials (Based on Availability)
11.2.13. Genesis Medtech
11.2.13.1. Overview
11.2.13.2. Products
11.2.13.3. SWOT Analysis
11.2.13.4. Recent Developments
11.2.13.5. Strategies
11.2.13.6. Financials (Based on Availability)
11.2.14. CooperSurgical Inc.
11.2.14.1. Overview
11.2.14.2. Products
11.2.14.3. SWOT Analysis
11.2.14.4. Recent Developments
11.2.14.5. Strategies
11.2.14.6. Financials (Based on Availability)
11.2.15. Intuitive Surgical
11.2.15.1. Overview
11.2.15.2. Products
11.2.15.3. SWOT Analysis
11.2.15.4. Recent Developments
11.2.15.5. Strategies
11.2.15.6. Financials (Based on Availability)
11.2.16. Frankenman International Ltd.
11.2.16.1. Overview
11.2.16.2. Products
11.2.16.3. SWOT Analysis
11.2.16.4. Recent Developments
11.2.16.5. Strategies
11.2.16.6. Financials (Based on Availability)

$4,850
$6,850

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings